| Literature DB >> 24487434 |
Shoukat Afshar-Sterle1, Dimitra Zotos1, Nicholas J Bernard1, Anna K Scherger2, Lisa Rödling2, Amber E Alsop2, Jennifer Walker2, Frederick Masson2, Gabrielle T Belz2, Lynn M Corcoran2, Lorraine A O'Reilly2, Andreas Strasser2, Mark J Smyth3, Ricky Johnstone4, David M Tarlinton2, Stephen L Nutt2, Axel Kallies2.
Abstract
Loss of function of the tumor suppressor gene PRDM1 (also known as BLIMP1) or deregulated expression of the oncogene BCL6 occurs in a large proportion of diffuse large B cell lymphoma (DLBCL) cases. However, targeted mutation of either gene in mice leads to only slow and infrequent development of malignant lymphoma, and despite frequent mutation of BCL6 in activated B cells of healthy individuals, lymphoma development is rare. Here we show that T cells prevent the development of overt lymphoma in mice caused by Blimp1 deficiency or overexpression of Bcl6 in the B cell lineage. Impairment of T cell control results in rapid development of DLBCL-like disease, which can be eradicated by polyclonal CD8(+) T cells in a T cell receptor-, CD28- and Fas ligand-dependent manner. Thus, malignant transformation of mature B cells requires mutations that impair intrinsic differentiation processes and permit escape from T cell-mediated tumor surveillance.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24487434 DOI: 10.1038/nm.3442
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 53.440